75 filings
Page 4 of 4
8-K/A
du5epuf dv1s9kivv7
1 Mar 19
Report of Independent Registered Public Accounting Firm
8:55am
8-K
uelc yv1jjkj
28 Feb 19
Amneal Reports Fourth Quarter and Full Year 2018 Financial Results
8:02am
8-K
790ekfq thctxdb6vx
24 Jan 19
Departure of Directors or Certain Officers
4:25pm
8-K
lx25qu sbf7ty
8 Jan 19
Regulation FD Disclosure
9:14am
8-K
c7z5i 36x
7 Jan 19
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer and Corporate Secretary
4:23pm
8-K
dhedr9wt3
7 Dec 18
Other Events
4:24pm
8-K
01bqt93m 9x8
7 Nov 18
Amneal Announces Solid Third Quarter 2018 Financial Results
7:02am
8-K
9by1x9l9f98
9 Aug 18
Amneal Announces Solid Second Quarter 2018 Financial Results
7:27am
8-K/A
56sasu58h
12 Jul 18
Financial Statements and Exhibits
12:00am
8-K
m7t2djj7s snutyptu
7 Jun 18
Impax Laboratories, LLC Announces Results Of Tender Offer for 2.00% Convertible Senior Notes Due 2022
4:33pm
8-K
xxpt32
21 May 18
Regulation FD Disclosure
8:09am
8-K
wj2s8uv9lox8m3bc
16 May 18
Cost Associated with Exit or Disposal Activities
4:42pm
8-K/A
12u7m
10 May 18
Financial Statements and Exhibits
12:00am
8-K
l8vzl37
7 May 18
Entry into a Material Definitive Agreement
7:44am
8-K
wmny8rpdcui12q
7 May 18
Amneal and Impax Complete Business Combination
7:06am